LANDON, GREATER LANDON, UK, December 20, 2023 /EINPresswire.com/ -- Business Research Company's Year-End Special: Get a 33% discount on Opportunities and Strategies Reports and a 25% discount on Global Market Reports.
The Business Research Company’s “Inactivated Vaccines Global Market Report 2024 is a comprehensive source of information that covers every facet of the market. As per TBRC’s market forecast, the inactivated vaccines market size is predicted to reach the inactivated vaccines market size has grown steadily in recent years. It will grow from $5.95 billion in 2023 to $6.19 billion in 2024 at a compound annual growth rate (CAGR) of 4.2%. The growth in the historic period can be attributed to polio eradication efforts, influenza vaccination programs, emerging infectious diseases, regulatory approvals. The inactivated vaccines market size is expected to see steady growth in the next few years. It will grow to $7.33 billion in 2028 at a compound annual growth rate (CAGR) of 4.3%.
The growth in the inactivated vaccines market is due to the increasing prevalence of infectious diseases. North America region is expected to hold the largest inactivated vaccines market share. Major players in the inactivated vaccines market include Pfizer Inc., Johnson & Johnson Services Inc., Sinopharm Group Co. Ltd., Merck & Co. Inc., Sanofi S.A., GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited.
Inactivated Vaccines Market Segments
• By Type: Viral Vaccine, Bacterial Vaccine
• By Method Of Inactivation: Solvent Detergent, Radiation, pH Concentration, Heat Inactivation, Other Methods Of Inactivation
• By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels
• By Geography: The global inactivated vaccines market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
Learn More On The Market By Requesting A Free Sample (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=13018&type=smp
Inactivated vaccines, also known as killed vaccines, are a type of vaccine that contains viruses or bacteria that have been killed or inactivated using heat, chemicals, or radiation. These vaccines are designed to stimulate an immune response without causing disease in the vaccinated individual.
Read More On The Inactivated Vaccines Global Market Report At:
https://www.thebusinessresearchcompany.com/report/inactivated-vaccines-global-market-report
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Inactivated Vaccines Market Characteristics
3. Inactivated Vaccines Market Trends And Strategies
4. Inactivated Vaccines Market – Macro Economic Scenario
5. Inactivated Vaccines Market Size And Growth
……
27. Inactivated Vaccines Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Market
29. Inactivated Vaccines Market Future Outlook and Potential Analysis
30. Appendix
Browse Through More Similar Reports By The Business Research Company
Swine Vaccines Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/swine-vaccines-global-market-report
Meningococcal Vaccines Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/meningococcal-vaccines-global-market-report
Cancer Vaccines Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report
Contact Information
The Business Research Company: https://www.thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]
Check out our:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
Twitter
LinkedIn
